Riskpilot← Back to searchSign inGet full accessBUSKERUD ØYEKLINIKK AS
ASIn liquidationOrg 987282339Blåbærsvingen 41, 0789 OsloMedical specialists activities · NACE 8622Est. 20046 employees
Revenue 2025
NOK 3,9M
-49% vs 2024
EBITDA margin
3.8%
-87% vs 2024
Equity ratio
46.1%
Financial strength
Net profit 2025
NOK 2,9M
+332% vs 2024
| Revenue | NOK 3,9M | -49% |
| EBITDA | NOK 145K | -87% |
| Net profit | NOK 2,9M | +332% |
| Total assets | NOK 2,1M | +29% |
| Equity | NOK 965K | +42% |
| Employees | 6 | — |
Legal name
BUSKERUD ØYEKLINIKK AS
Org number
987282339
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
28. september 2004
Share capital
NOK 100 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Å drive legevirksomhet og annen medisinsk virksomhet, eie fast eiendom, drive konsulent og investeringsvirksomhet, samt å delta i selskaper med lignende virksomhet.
Address
Blåbærsvingen 41, 0789 Oslo
Phone
+4732127100
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 495 | 6 924 | 7 285 | 7 558 | 3 855 |
| Staff expenses | −3 905 | −4 019 | −4 105 | −4 243 | −2 419 |
| EBITDA | 840 | 920 | 865 | 1 079 | 145 |
| Depreciation & amort. | −221 | −230 | −256 | −247 | −71 |
| EBIT | 619 | 690 | 609 | 831 | 73 |
| Net financials | −0 | −1 | 6 | 31 | 3 742 |
| Profit before tax | 619 | 688 | 615 | 862 | 3 815 |
| Tax | 136 | 151 | 136 | 190 | 911 |
| Net profit | 483 | 537 | 479 | 672 | 2 904 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 461 | 1 606 | 1 507 | 1 628 | 2 093 |
| Equity | 592 | 729 | 608 | 681 | 965 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 869 | 877 | 899 | 947 | 1 128 |
| Total debt | 869 | 877 | 899 | 947 | 1 128 |
EBITDA margin
3.8%
This company
15.8%
Market median
-76% vs market
20212025
Equity ratio
46.1%
This company
38.2%
Market median
+21% vs market
20212025
Return on equity
301.0%
This company
18.4%
Market median
+1536% vs market
20212025
Net profit margin
75.3%
This company
8.1%
Market median
+830% vs market
20212025
Asset turnover
1.84×
This company
1.12×
Market median
+64% vs market
20212025
Debt / equity
1.17×
This company
0.62×
Market median
-89% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
DE Deputy Member | Deputy Member | 2011 |
AG Chief Executive Officer | Chief Executive Officer | 2007 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2011 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BUSKERUD ØYEKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dag Erik Eriksen | Deputy Member | 0 companies |
| Anne-Christine Grime | Chief Executive Officer | 0 companies |
| Eystein Liavaag | Chairman | 0 companies |